PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
TXG vs. DHR
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between TXG and DHR is 0.43, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.4

Performance

TXG vs. DHR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in 10x Genomics, Inc. (TXG) and Danaher Corporation (DHR). The values are adjusted to include any dividend payments, if applicable.

-30.00%-20.00%-10.00%0.00%10.00%20.00%JulyAugustSeptemberOctoberNovemberDecember
-29.01%
-10.18%
TXG
DHR

Key characteristics

Sharpe Ratio

TXG:

-1.14

DHR:

0.05

Sortino Ratio

TXG:

-2.22

DHR:

0.24

Omega Ratio

TXG:

0.73

DHR:

1.03

Calmar Ratio

TXG:

-0.80

DHR:

0.05

Martin Ratio

TXG:

-1.32

DHR:

0.17

Ulcer Index

TXG:

56.30%

DHR:

7.14%

Daily Std Dev

TXG:

65.09%

DHR:

22.28%

Max Drawdown

TXG:

-93.49%

DHR:

-65.35%

Current Drawdown

TXG:

-93.11%

DHR:

-21.45%

Fundamentals

Market Cap

TXG:

$1.78B

DHR:

$168.67B

EPS

TXG:

-$1.52

DHR:

$5.30

Total Revenue (TTM)

TXG:

$629.74M

DHR:

$20.03B

Gross Profit (TTM)

TXG:

$414.92M

DHR:

$11.94B

EBITDA (TTM)

TXG:

-$131.06M

DHR:

$7.16B

Returns By Period

In the year-to-date period, TXG achieves a -75.09% return, which is significantly lower than DHR's -0.90% return.


TXG

YTD

-75.09%

1M

2.73%

6M

-30.16%

1Y

-74.45%

5Y*

-28.39%

10Y*

N/A

DHR

YTD

-0.90%

1M

-1.95%

6M

-10.17%

1Y

-0.37%

5Y*

11.48%

10Y*

20.46%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

TXG vs. DHR - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for 10x Genomics, Inc. (TXG) and Danaher Corporation (DHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for TXG, currently valued at -1.14, compared to the broader market-4.00-2.000.002.00-1.140.05
The chart of Sortino ratio for TXG, currently valued at -2.22, compared to the broader market-4.00-2.000.002.004.00-2.220.24
The chart of Omega ratio for TXG, currently valued at 0.73, compared to the broader market0.501.001.502.000.731.03
The chart of Calmar ratio for TXG, currently valued at -0.80, compared to the broader market0.002.004.006.00-0.800.05
The chart of Martin ratio for TXG, currently valued at -1.32, compared to the broader market-5.000.005.0010.0015.0020.0025.00-1.320.17
TXG
DHR

The current TXG Sharpe Ratio is -1.14, which is lower than the DHR Sharpe Ratio of 0.05. The chart below compares the historical Sharpe Ratios of TXG and DHR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-2.00-1.000.001.002.00JulyAugustSeptemberOctoberNovemberDecember
-1.14
0.05
TXG
DHR

Dividends

TXG vs. DHR - Dividend Comparison

TXG has not paid dividends to shareholders, while DHR's dividend yield for the trailing twelve months is around 0.46%.


TTM20232022202120202019201820172016201520142013
TXG
10x Genomics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
DHR
Danaher Corporation
0.46%0.43%0.38%0.26%0.32%0.44%0.62%0.60%36.46%0.80%0.47%0.13%

Drawdowns

TXG vs. DHR - Drawdown Comparison

The maximum TXG drawdown since its inception was -93.49%, which is greater than DHR's maximum drawdown of -65.35%. Use the drawdown chart below to compare losses from any high point for TXG and DHR. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-93.11%
-21.45%
TXG
DHR

Volatility

TXG vs. DHR - Volatility Comparison

10x Genomics, Inc. (TXG) has a higher volatility of 20.42% compared to Danaher Corporation (DHR) at 6.06%. This indicates that TXG's price experiences larger fluctuations and is considered to be riskier than DHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%35.00%JulyAugustSeptemberOctoberNovemberDecember
20.42%
6.06%
TXG
DHR

Financials

TXG vs. DHR - Financials Comparison

This section allows you to compare key financial metrics between 10x Genomics, Inc. and Danaher Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab